[New approach for the absorbent therapy of verotoxin-producing Escherichia coli infection].
Takeda
T
T
National Children's Medical Research Center, Department of Infectious Diseases Research.
Yoshino
K
K
Matsuda
E
E
D000327:Adsorption; D000595:Amino Acid Sequence; D001427:Bacterial Toxins / Q000737:chemistry; D002986:Clinical Trials as Topic; D004927:Escherichia coli Infections / Q000628:therapy*; D019453:Escherichia coli O157; D006801:Humans; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000627:therapeutic use*; D022622:Shiga Toxin 1; D012822:Silicon Dioxide; D014281:Trihexosylceramides / Q000627:therapeutic use*
D001427:Bacterial Toxins; D009844:Oligosaccharides; D022622:Shiga Toxin 1; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D012822:Silicon Dioxide